American Thyroid Association® Satellite Symposium: Personalized Approach to Thyroid Disorders
Friday, March 27, 2020, 1:00 PM – 5:30 PM
Moscone Convention Center, San Francisco, California
(Prior to the start of ENDO 2020)
Laura Boucai, MD, Memorial Sloan Kettering Cancer Center
Francesco S. Celi, MD, MHSc, Virginia Commonwealth University
The management of thyroid disorders is becoming increasingly complex as clinicians and patients strive to develop individualized diagnostic and therapeutic strategies designed to balance evidence-based medicine with patient-specific characteristics and rising health care costs, while attempting to achieve excellent clinical outcomes. Varying reference ranges according to age, race, and body mass index in pregnant and non-pregnant populations have caused physicians to re-evaluate traditional therapeutic approaches to include alternative algorithms that fit the specific population they treat. Similarly, the risk-adapted information provided by long-term studies of microcarcinomas and new developments in the molecular characterization of tumors have allowed patients to consider limited surgeries and even active surveillance strategies that deviate from the traditional recommendation of aggressive management of thyroid cancer. Through a combination of lectures, panel discussions, and case-based presentations, we will examine the most important, and often controversial, management issues faced by clinicians across the full spectrum of thyroid disorders. Ultimately the goal of this Symposium is to provide participants the tools to design a personalized, patient-centered approach to the care of patients with thyroid disorders.
Upon completion of this educational activity, learners will be able to:
- Describe demographic factors that make clinicians evaluate pregnant patients for treatment of thyroid disorders.
- Explain the indications, risks, and benefits of treating pregnant patients with thyroid disease.
- Understand the specific concerns to be taken into account when evaluating thyroid diseases in the pediatric and adolescent population.
- Explain challenging scenarios in the treatment of patients with hypothyroidism after thyroidectomy and autoimmune hypothyroidism.
- Illustrate different therapeutic strategies to manage patients with hyperthyroidism according to the etiology of their disease.
- Understand the utility of decision-support tools to help patients and physicians discuss different treatment modalities in the management of hyperthyroidism and thyroid cancer.
- Identify the specific scenarios in which molecular testing of tumors becomes informative and provides the basis for an individualized therapeutic strategy.
Registration Fees for ATA/ENDO member, non-member, and in-Trainee
- $199 – ATA Member or ENDO Member
- $229 – Non-Member
- $79 – ATA Associate Member/Trainees
Registration Codes for ATA/ENDO Members
- ATA/Endocrine Society Members ATAMEM
- ATA/Endocrine Society In‐Training Members ATATRN
- ATA complimentary registration for speakers ATACR
Agenda details will be posted in December/January 2019.
We look forward to your participation